DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $208,704 | -55.2% | 869 | -45.3% | 0.03% | -25.0% |
Q1 2022 | $466,000 | -98.8% | 1,589 | -98.6% | 0.04% | -98.5% |
Q4 2021 | $38,183,000 | +11.9% | 116,053 | +3.5% | 2.95% | -1.3% |
Q3 2021 | $34,131,000 | +14.1% | 112,112 | +0.6% | 2.99% | +24.4% |
Q2 2021 | $29,918,000 | +24.0% | 111,484 | +4.0% | 2.40% | +5.8% |
Q1 2021 | $24,130,000 | +8.2% | 107,206 | +6.8% | 2.27% | -5.4% |
Q4 2020 | $22,307,000 | +5.6% | 100,419 | +2.4% | 2.40% | -10.8% |
Q3 2020 | $21,116,000 | +23.6% | 98,063 | +1.5% | 2.69% | +0.3% |
Q2 2020 | $17,083,000 | +37.7% | 96,608 | +7.8% | 2.68% | -11.8% |
Q1 2020 | $12,409,000 | +48.7% | 89,657 | -18.4% | 3.04% | +63.5% |
Q3 2014 | $8,347,000 | -1.2% | 109,854 | +2.4% | 1.86% | -6.6% |
Q2 2014 | $8,445,000 | +6.6% | 107,271 | +1.6% | 1.99% | +3.5% |
Q1 2014 | $7,921,000 | +1.9% | 105,619 | +4.9% | 1.92% | -0.9% |
Q4 2013 | $7,776,000 | +11.6% | 100,720 | +0.2% | 1.94% | +3.1% |
Q3 2013 | $6,970,000 | +6.5% | 100,555 | -2.7% | 1.88% | -4.7% |
Q2 2013 | $6,544,000 | – | 103,385 | – | 1.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |